Vitamin D and chronic obstructive pulmonary disease: Hype or reality?

The Lancet Respiratory Medicine

Volumn 1, Issue 10, 2013, Pages 804-812

  Janssens, Wim ^a   Decramer, Marc ^a   Mathieu, Chantal ^a   Korf, Hannelie ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; PLACEBO; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; VITAMIN D;

ADAPTIVE IMMUNITY; BONE DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; GENETIC TRANSCRIPTION; HIGH RISK PATIENT; HISTONE ACETYLATION; HUMAN; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LOADING DRUG DOSE; LUNG FUNCTION; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; RISK FACTOR; SMOKING; SUN EXPOSURE; TRANSCRIPTION REGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D RESPONSIVE ELEMENT; VITAMIN INTAKE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; HEALTH; INCIDENCE; METABOLISM; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

GLOBAL HEALTH; HUMANS; INCIDENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84888873567     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70102-4     Document Type: Review

References (79)

1. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012, 156:105-114.
2. Kunisaki KM, Niewoehner DE, Connett JE Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med 2012, 185:286-290.
3. Shaheen SO, Jameson KA, Robinson SM, et al. Relationship of vitamin D status to adult lung function and COPD. Thorax 2011, 66:692-698.
4. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010, 10:482-496.
5. Litonjua AA Vitamin D deficiency as a risk factor for childhood allergic disease and asthma. Curr Opin Allergy Clin Immunol 2012, 12:179-185.
6. Daley D, Lemire M, Akhabir L, et al. Analyses of associations with asthma in four asthma population samples from Canada and Australia. Hum Genet 2009, 125:445-459.
7. Brehm JM, Celedon JC, Soto-Quiros ME, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009, 179:765-771.
8. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009, 179:630-636.
9. Holick MF Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
10. Ross AC The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr 2011, 14:938-939.
11. Black PN, Scragg R Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005, 128:3792-3798.
12. Lange NE, Sparrow D, Vokonas P, Litonjua AA Vitamin D deficiency, smoking, and lung function in the normative aging study. Am J Respir Crit Care Med 2012, 186:616-621.
13. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010, 65:215-220.
14. Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 2012, 7:e38934.
15. Holmgaard DB, Mygind LH, Titlestad IL, et al. Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality-results from a 10-year prospective cohort study. PLoS One 2013, 8:e53670.
16. Quint JK, Donaldson GC, Wassef N, Hurst JR, Thomas M, Wedzicha JA 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease. BMC Pulm Med 2012, 12:28.
17. Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J 2011, 37:238-243.
18. Romme EA, Rutten EP, Smeenk FW, Spruit MA, Menheere PP, Wouters EF Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med 2013, 45:91-96.
19. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007, 175:458-463.
20. Sinotte M, Diorio C, Berube S, Pollak M, Brisson J Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 2009, 89:634-640.
21. Bakke PS, Zhu G, Gulsvik A, et al. Candidate genes for COPD in two large data sets. Eur Respir J 2011, 37:255-263.
22. Ishii T, Keicho N, Teramoto S, et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 2001, 18:753-757.
23. Wood AM, Bassford C, Webster D, et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax 2011, 66:205-210.
24. Heulens N, Decramer M, Janssens W Severe vitamin D deficiency: a biomarker of exacerbation risk?. Am J Respir Crit Care Med 2013, 187:214-215.
25. Chalmers JD, McHugh BJ, Docherty C, Govan JR, Hill AT Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax 2013, 68:39-47.
26. Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab 2012, 97:2644-2652.
27. Zella LA, Meyer MB, Nerenz RD, Lee SM, Martowicz ML, Pike JW Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol 2010, 24:128-147.
28. Sundar IK, Rahman I Vitamin d and susceptibility of chronic lung diseases: role of epigenetics. Front Pharmacol 2011, 2:50.
29. Barnes PJ Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 2009, 71:451-464.
30. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005, 352:1967-1976.
31. An BS, Tavera-Mendoza LE, Dimitrov V, et al. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol Cell Biol 2010, 30:4890-4900.
32. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 2007, 103:558-562.
33. Urry Z, Xystrakis E, Richards DF, et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 2009, 119:387-398.
34. Joshi S, Pantalena LC, Liu XK, et al. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 2011, 31:3653-3669.
35. Decramer M, Janssens W, Miravitlles M Chronic obstructive pulmonary disease. Lancet 2012, 379:1341-1351.
36. Cosio MG, Saetta M, Agusti A Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-2454.
37. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008, 181:7090-7099.
38. Overbergh L, Decallonne B, Valckx D, et al. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 2000, 120:139-146.
39. Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012, 188:2127-2135.
40. Korf H, Wenes M, Stijlemans B, et al. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 2012, 217:1292-1300.
41. Ferreira GB, van Etten E, Verstuyf A, et al. 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev 2011, 27:933-941.
42. low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol 2011, 186:132-142.
43. Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009, 183:5458-5467.
44. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol 2008, 180:5211-5221.
45. Bruce D, Yu S, Ooi JH, Cantorna MT Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 2011, 23:519-528.
46. Song Y, Qi H, Wu C Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology 2007, 12:486-494.
47. Banerjee A, Panettieri R Vitamin D modulates airway smooth muscle function in COPD. Curr Opin Pharmacol 2012, 12:266-274.
48. Wedzicha JA, Seemungal TA COPD exacerbations: defining their cause and prevention. Lancet 2007, 370:786-796.
49. Sethi S, Murphy TF Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008, 359:2355-2365.
50. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004, 173:2909-2912.
51. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
52. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998, 42:2206-2214.
53. Sly LM, Guiney DG, Reiner NE Salmonella enterica serovar typhimurium periplasmic superoxide dismutases SodCI and SodCII are required for protection against the phagocyte oxidative burst. Infect Immun 2002, 70:5312-5315.
54. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010, 184:965-974.
55. Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
56. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
57. Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010, 35:1039-1047.
58. Matsunawa M, Amano Y, Endo K, et al. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci 2009, 109:50-58.
59. Jeffery LE, Wood AM, Qureshi OS, et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol 2012, 189:5155-5164.
60. Uh ST, Koo SM, Kim YK, et al. Inhibition of vitamin d receptor translocation by cigarette smoking extracts. Tuberc Respir Dis (Seoul) 2012, 73:258-265.
61. Sundar IK, Hwang JW, Wu S, Sun J, Rahman I Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun 2011, 406:127-133.
62. Coughlan CA, Chotirmall SH, Renwick J, et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am J Respir Crit Care Med 2012, 186:999-1007.
63. Ito K, Barnes PJ COPD as a disease of accelerated lung aging. Chest 2009, 135:173-180.
64. Tuohimaa P Vitamin D and aging. J Steroid Biochem Mol Biol 2009, 114:78-84.
65. Yao H, Chung S, Hwang JW, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest 2012, 122:2032-2045.
66. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:861-870.
67. Barnes PJ, Adcock IM Glucocorticoid resistance in inflammatory diseases. Lancet 2009, 373:1905-1917.
68. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J 2000, 14:1455-1463.
69. Kunisaki KM, Rector TS Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011, 6:29-34.
70. Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006, 116:146-155.
71. Papaioannou AI, Rossios C, Kostikas K, Ito K Can we delay the accelerated lung aging in COPD? Anti-aging molecules and interventions. Curr Drug Targets 2013, 14:149-157.
72. Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med 2011, 183:1336-1343.
73. Gold DR, Manson JE Severe vitamin D deficiency: a prerequisite for COPD responsiveness to vitamin D supplementation?. Ann Intern Med 2012, 156:156-157.
74. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303:1815-1822.
75. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012, 95:1357-1364.
76. Sakalli H, Arslan D, Yucel AE The effect of oral and parenteral vitamin D supplementation in the elderly: a prospective, double-blinded, randomized, placebo-controlled study. Rheumatol Int 2012, 32:2279-2283.
77. Takano Y, Mitsuhashi H, Ishizuka S, et al. TEI-A00114: a new vitamin D3 analogue that inhibits neutrophil recruitment in an acute lung injury hamster model while showing reduced hypercalcemic activity. Steroids 2012, 77:1535-1542.
78. Slomski A IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 2011, 305:453-454. 456.
79. Lehouck A, Boonen S, Decramer M, Janssens W COPD, bone metabolism, and osteoporosis. Chest 2011, 139:648-657.